The company can market chair health-monitoring systems to hospitals and nursing homes in the US.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at email@example.com.
EarlySense, developer and marketer of a hospital bed monitoring device, has developed a chair to perform the same task, and the product has received US Food and Drug Administration (FDA) approval for marketing in the US.
The company is currently seeking to bring this ability to hospital and nursing home chairs as well. Patients who do not require intensive care are generally not required to lie in bed all day, rather the opposite. It is better that they get out of bed, walk around, and sit, in order to improve lung function, and prevent emboli and the like. A chair that could monitor their conditions, particularly one that could do so without requiring that they be connected to any machines, could encourage patients to leave the safety of their beds.
According to the company, the chair can monitor the patient’s heart rate, respiration, and activity level. In a trial conducted at a hospital with which the company works, it was found that it is effective in preventing some cases of patient deterioration and falls.
Published by Globes [online], Israel business news – www.globes-online.com